Lipid variability and risk of microvascular complications in Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: A post hoc analysis is a research paper published in Journal of Diabetes (2022). On theSindex it has a DataRank of 0.762. It has been cited 19 times, with 17 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0.313
From 10 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 17 citers.
National Natural Science Foundation of China
Grant: 82173607
Guangdong Basic and Applied Basic Research Foundation
Grant: 2021A1515011684
Open Project of the Guangdong Provincial Key Laboratory of Tropical Disease Research
Grant: 2020B1212060042
Guangzhou Science and Technology Project
Grant: 202102080597
National Institutes of Health
Grant: N01HC095181-001
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITU
National Institutes of Health
Grant: N01HC095179-001
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITU
National Institutes of Health
Grant: N01HC095183-001
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITU
National Institutes of Health
Grant: N01HC095182-002
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITU
National Institutes of Health
Grant: N01HC095178-000
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITU
National Institutes of Health
Grant: N01HC095184-000
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITU
National Institutes of Health
Grant: N01HC095180-001
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETER MELLLIT
NIDDK NIH HHS
National Eye Institute
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Abbott Laboratories
National Heart, Lung, and Blood Institute
National Institute on Aging
NEI NIH HHS
NIA NIH HHS
Centers for Disease Control and Prevention
King Pharmaceuticals
Novo Nordisk
Bayer HealthCare
CDC HHS
NHLBI NIH HHS
NIH HHS
Novo Nordisk
King Pharmaceuticals
Bayer HealthCare
Abbott Laboratories
CDC HHS
NEI NIH HHS
NIA NIH HHS
NIDDK NIH HHS
NIH HHS
NHLBI NIH HHS
CDC HHS
NEI NIH HHS
NIA NIH HHS
NIDDK NIH HHS
NIH HHS
NHLBI NIH HHS
FWCI
2.13
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals